FROM BAGGIE TO BAGGED –
Mar. 5, 2026 – In 1974, Janssen Pharmaceuticals chemists synthesized a compound so potent a few micrograms immobilized an elephant or rhinoceros. Marketed as Wildnil for wildlife anesthesia, carfentanil was used for decades to tranquilize large animals. Commercial production ended in 2003, and the drug vanished from veterinary supply chains. For years, it seemed destined to remain a historical footnote in veterinary pharmacology. However, in recent years, carfentanil has reemerged as a clandestinely-manufactured powder infiltrating human drug markets. Its clinical danger lies in its extreme potency. According to the DEA and investigative reporting, most illicit carfentanil originates from Chinese underground laboratories. Mexican drug trafficking organizations import the finished product or precursor chemicals, and then distribute to the United States and Canada.
Carfentanil is about 10,000 times more potent than morphine and 100 times more potent than fentanyl. The margin between intoxication and death is vanishingly small, particularly with polysubstance use. As clinicians have observed, carfentanil can rapidly cause death. Naloxone (Narcan) reversal must be swift and often requires repeated or high dosing with close monitoring. The interval between exposure and death may be as short as minutes.
